India’s anti-obesity drug market quadruples in five years on lifestyle disease surge
India’s anti-obesity drug market has grown more than fourfold in the last five years fuelled by rising instances of lifestyle diseases along with greater affordability and willingness among a section…
Popular diabetes drug, Mounjaro, launched in India
Mounjaro (tirzepatide): A breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization…
Pharma companies turn to AI to speed up drug development, but hit hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…